These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31813290)

  • 21. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naïve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study.
    Iglicki M; Khoury M; Melamud JI; Donato L; Barak A; Quispe DJ; Zur D; Loewenstein A
    Eye (Lond); 2023 Jun; 37(8):1659-1664. PubMed ID: 36038720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of multilevel macular hemorrhage secondary to retinal arterial macroaneurysm with submacular tissue plasminogen activator.
    Sonmez K; Ozturk F; Ozcan PY
    Eur J Ophthalmol; 2012; 22(6):1026-31. PubMed ID: 22467586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
    Caporossi T; Bacherini D; Governatori L; Oliverio L; Di Leo L; Tartaro R; Rizzo S
    Acta Ophthalmol; 2022 Aug; 100(5):e1143-e1152. PubMed ID: 34609787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L; Saad AAA; Vaideanu-Collins D; Isac M; Hamada D; El-Haig WM
    Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E; Delaere L; Vaninbroukx I; Van Calster J; Stalmans P
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract]   [Full Text] [Related]  

  • 28. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
    Patikulsila D; Winaikosol P; Choovuthayakorn J; Watanachai N; Chaikitmongkol V; Kunavisarut P
    BMC Ophthalmol; 2022 Oct; 22(1):411. PubMed ID: 36303103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
    Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R; Mavi Yıldız A; Çınar E; Yılmaz S; Küçükerdönmez C; Akalp FD; Avcı E
    Turk J Ophthalmol; 2021 Feb; 51(1):38-44. PubMed ID: 33631914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
    Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
    Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.
    González-López JJ; McGowan G; Chapman E; Yorston D
    Eye (Lond); 2016 Jul; 30(7):929-35. PubMed ID: 27055681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA; Nawrocki J
    Ophthalmologica; 2024; 247(1):58-64. PubMed ID: 38113868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.
    van Zeeburg EJ; Cereda MG; van Meurs JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):733-40. PubMed ID: 22865261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VITRECTOMY WITH SUBRETINAL INJECTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE WITH OR WITHOUT VITREOUS HEMORRHAGE.
    Shi T; Wen J; Xia H; Chen H
    Retina; 2024 Jul; 44(7):1188-1195. PubMed ID: 38452260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Hirashima T; Moriya T; Bun T; Utsumi T; Hirose M; Oh H
    Retina; 2015 Oct; 35(10):1969-78. PubMed ID: 26079475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator.
    Cakir M; Cekiç O; Yilmaz OF
    Eur J Ophthalmol; 2010; 20(3):565-71. PubMed ID: 20037915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gravitational displacement of submacular haemorrhage in patients with age-related macular disease.
    Erdogan G; Kirmaci A; Perente I; Artunay O
    Eye (Lond); 2020 Jun; 34(6):1136-1141. PubMed ID: 31792350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.